← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 13, 2018Last known activity
Dec 31, 2020
Acquired by Organon → Schering-Plough → Merck on Nov 13, 2021
Timeline
Drugs by trial phase (1 distinct, 2 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04686669Lead sponsorPhase 1Dec 31, 2020
- NCT03709420Lead sponsorPhase 1Aug 13, 2018
Details
- Founded
- Turku, FI Jun 1, 2013
- Last known activity
- Dec 31, 2020